Scottish NeuroMotor pen gains FDA Breakthrough Device Designation

Scottish tech firm Manus Neurodynamica has been granted Breakthrough Designation by the US FDA for its NeuroMotor Pen device.

FDA approves Abbott's new spinal cord stimulation device - IndiaMedToday

Neuromotor Pen – Manus Neurodynamica

Neuros Medical receives Breakthrough Device Designation from FDA

Neuropen Device Hopkins Medical Products

Andy Stuart on LinkedIn: #hiddendisabilities #snp21 #abuse #hostileenvironment #educate…

Neuromotor Pen – Manus Neurodynamica

FDA awards Neuralert Technologies Breakthrough Device designation - Penn Center for Innovation

Abbott's Neuromodulation Products

NMPA Innovation Approval January- China Med Device

Wallaby Medical Obtained FDA 510k Clearance for its Esperance™ 5F & 6F Aspiration Catheter - NEWS - Wallaby Medical

Manus Neurodynamica secures £2.6m funding to advance NeuroMotor Pen - Med-Tech Innovation

Neuromotor Pen – Manus Neurodynamica

EarlyTect BCD a Breakthrough Device for Bladder Cancer Detection

Unbabel acquires Scots-based language translation company Lingo24